Reactions Weekly

, Volume 1223, Issue 1, pp 3–3 | Cite as

Merck & Co can taranabant for obesity

Media release
  • 8 Downloads

Keywords

Public Health Adverse Event Obesity Development Program Clinical Development 

REFERENCE

  1. 1.
    Merck & Co Inc.Merck Discontinues Development of Investigational Medicine Taranabant for Obesity. Media Release: 3 Oct 2008. Available from: URL: http://www.merck.com

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations